Shandong Weigao Group Medical Polymer Company Limited 01066.HK 上一季度的收入表现如何?
Shandong Weigao Group Medical Polymer Company Limited 的收入预期是多少?
Shandong Weigao Group Medical Polymer Company Limited 的盈利质量评分是多少?
Shandong Weigao Group Medical Polymer Company Limited 何时发布财报?
Shandong Weigao Group Medical Polymer Company Limited 的预期收益是多少?
Shandong Weigao Group Medical Polymer Company Limited 是否超出收益预期?
关键数据
前收盘价
$5.2
开盘价
$5.2
当日区间
$5.05 - $5.2
52周范围
$4.59 - $7.39
交易量
4.7M
平均成交量
14.1M
每股收益(TTM)
0.48
股息收益率
--
市值
$22.8B
什么是 WEIGAO GROUP?
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 13,063 full-time employees. The company went IPO on 2004-02-27. The firm operates its businesses through six segments. The Medical Device segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The firm mainly operates its businesses in the domestic and overseas markets.